RV

Ram Vilash Ray

Active Director Additional Director DIN 11101679
DIN 11101679 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ram Vilash Ray

Data last updated:

Ram Vilash Ray is an Additional Director at Livozen Medicare Private Limited (since 2025).

DIN 11101679
Primary Designation Additional Director
First Appointment 07 Apr 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Livozen Medicare Private Limited U46497DL2023PTC423366
Additional Director07 Apr 20252023Active

Board colleagues of Ram Vilash Ray

NameDINCompanyDesignation
Arti Kumari10413135Livozen Medicare Private LimitedDirector
Suryadev Prasad Yadav10413136Livozen Medicare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Livozen Medicare Private Limited
Premium access

Shareholding and investment profile for Ram Vilash Ray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Vilash Ray

Ram Vilash Ray currently holds 1 directorship: Livozen Medicare Private Limited (Additional Director, since 07 Apr 2025).

Ram Vilash Ray was first appointed on 07 Apr 2025 as Additional Director at Livozen Medicare Private Limited.

The current boards of Ram Vilash Ray's companies include Arti Kumari (Livozen Medicare Private Limited), Suryadev Prasad Yadav (Livozen Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available